Failure to thrive: The earliest feature of cystic fibrosis in infants diagnosed by neonatal screening

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 11, 1997, Pages 1162-1165

  Giglio, L ^a   Candusso, M ^a   D'Orazio, C ^b   Mastella, G ^b   Faraguna, D ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b BORGO TRENTO HOSPITAL   (Italy)

Author keywords

Cystic fibrosis; Early diagnosis; Growth failure; Neonatal screening

Indexed keywords

CHYMOTRYPSIN; LACTASE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FAILURE TO THRIVE; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MECONIUM; NEWBORN SCREENING; PRIORITY JOURNAL; SWEAT TEST; SYMPTOMATOLOGY;

EID: 0030665216     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb14836.x     Document Type: Article

References (25)

1. Wilken B, Towns SJ, Mellis CM. Diagnostic delay in cystic fibrosis: lessons from newborn screening. Arch Dis Child 1983; 58: 863-6
2. Tepper RS, Hiatt P, Eigen H, Scott P, Grosfeld J, Cohen M. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol 1988; 5: 15-8
3. Accurso FJ, Sokol RJ, Hammond KB, Abman SH. Early respiratory course in infants with cystic fibrosis: relevance to newborn screening. Pediatr Pulmonol 1991 ; Suppl 7: 42-5
4. Faraguna D, Giglio L, D'Orazio C, Pederzini F, de Vonderweid U, Mastella G. Is clinical status at diagnosis a prognostic factor in CF infants identified by neonatal screening? Pediatr Pulmonol 1991; Suppl 7: 46-51
5. Abman SH, Ogle JW, Harbeck RJ, Butler-Simon N, Hammond KB, Accurso FJ. Early bacteriologic, immunologic and clinical course of young infants with cystic fibrosis identified by neonatal screening. J Pediatr 1991; 119: 211-7
6. Reardon M, Hammond K, Accurso F, Fisher CD, McCabe ERB, Cotton EK, et al. Nutrition deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test. J Pediatr 1984; 105: 271-3
7. Green MR, Weaver LT, Heeley AF, Nicholson K, Kuzemko JA, Barton DE, et al. Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history. Arch Dis Child 1993; 68: 464-7
8. Farrell P, Mischler E. Newborn screening for cystic fibrosis. Adv Pediatr 1992; 39: 35-70
9. Orenstein DM, Boat TF, Stern RC, Tucker As, Charnock EL, Matthews EW, et al. The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of sibling pairs. Am J Dis Child 1977; 131: 973-5
10. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9
11. Ad Hoc Committee Task Force on Neonatal Screening, Cystic Fibrosis Foundation. Neonatal Screening for Cystic Fibrosis: Position Paper. Pediatrics 1983; 72: 741-5
12. Dankert-Roelse JE, Te Meerman GJ, Martijn A, ten Kate LP, Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr 1989; 114: 362-7
13. Wilcken B, Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet 1985; 2: 1319-21
14. Mastella G, Pederzini F, Girella E. Cystic fibrosis screening policy. Lancet 1984; ii: 575-6
15. Pederzini F, Faraguna D, Giglio L, Pedrotti D, Perobelli L, Mastella G. Development of screening system for cystic fibrosis: meconium or blood spot trypsin assay or both? Acta Paediatr Scand 1990; 79: 935-42
16. Pederzini F, Cabrini G, Faraguna D, Giglio L, Pedrotti D, Mastella G. Neonatal screening for cystic fibrosis using blood trypsin with complementary meconium lactase: an advisable strategy for the population of Southern Europe. Screening 1995; 3: 173-9
17. Abman SH, Reardon MC, Accurso FJ, Hammond KB, Sokol RJ. Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening. J Pediatr 1985; 107: 933-5
18. Bronstein MN, Sokol RJ, Abman SH, Chatfield BA, Hammond KB, Hambidge KM, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992; 120: 533-40
19. Reisman J, Petrou C, Corey M, Stringer D, Durie P, Levison H. Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr 1989; 115; 755-8
20. Marcus MS, Sondel SA, Farrell PM. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991; 54: 578-8
21. Mischler EH, Marcus MS, Sondel SA, Laxova A, Carey P, Langhough R, et al. Nutritional assessment of infants with cystic fibrosis diagnosed through screening. Pediatr Pulmonol 1991; Suppl 7: 56-63
22. Elliott R. Neonatal screening for cystic fibrosis: A historical perspective. Pediatrics 1991; 7: 7-10
23. Lyon I, Webster D. Neonatal screening for cystic fibrosis. Pediatrics 1991; 87: 954-5
24. Girella E, Faggionato P, Benetazzo D, Mastella G: The assay of chymotrypsin in stool as a simple and effective test of exocrine pancreatic activity in cystic fibrosis. Pancreas 1988; 3: 254-62
25. Brown GA, Halliday RB, Turner PJ, Smalley CA. Faecal chymotrypsin concentrations in neonates with cystic fibrosis and healthy controls. Arch Dis Child 1988; 63: 1229-33